{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:12:59Z","timestamp":1791238379107,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.leukres.2011.07.015","type":"journal-article","created":{"date-parts":[[2011,8,2]],"date-time":"2011-08-02T18:59:53Z","timestamp":1312311593000},"page":"1491-1497","source":"Crossref","is-referenced-by-count":35,"title":["Efficacy of novel histone deacetylase inhibitor, AR42, in a mouse model of, human T-lymphotropic virus type 1 adult T cell lymphoma"],"prefix":"10.1016","volume":"35","author":[{"given":"Bevin","family":"Zimmerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Sargeant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Landes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soledad A.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Shih","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Lairmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"December (4)","key":"10.1016\/j.leukres.2011.07.015_bib0005","first-page":"336","article-title":"HTLV-1 and associated adult T-cell leukemia\/lymphoma","volume":"7","author":"Mahieux","year":"2003","journal-title":"Rev Clin Exp Hematol"},{"issue":"July (3)","key":"10.1016\/j.leukres.2011.07.015_bib0010","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/CMR.00063-09","article-title":"Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases","volume":"23","author":"Goncalves","year":"2010","journal-title":"Clin Microbiol Rev"},{"issue":"20 January (3)","key":"10.1016\/j.leukres.2011.07.015_bib0015","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","article-title":"Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia\u2013lymphoma: a proposal from an international consensus meeting","volume":"27","author":"Tsukasaki","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.leukres.2011.07.015_bib0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3960\/jslrt.50.9","article-title":"Treatment of adult T-cell leukemia","volume":"50","author":"Uozumi","year":"2010","journal-title":"J Clin Exp Hematop"},{"issue":"3 November (9)","key":"10.1016\/j.leukres.2011.07.015_bib0025","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/sj.bjc.6605345","article-title":"Mechanisms of HTLV-1 persistence and transformation","volume":"101","author":"Boxus","year":"2009","journal-title":"Br J Cancer"},{"issue":"13 August (37)","key":"10.1016\/j.leukres.2011.07.015_bib0030","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1038\/sj.onc.1210620","article-title":"Histone deacetylase inhibitors: molecular mechanisms of action","volume":"26","author":"Xu","year":"2007","journal-title":"Oncogene"},{"issue":"January (1)","key":"10.1016\/j.leukres.2011.07.015_bib0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.biocel.2008.09.008","article-title":"Histone deacetylase inhibitors: anticancer compounds","volume":"41","author":"Smith","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"issue":"January (1)","key":"10.1016\/j.leukres.2011.07.015_bib0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.biocel.2008.07.020","article-title":"Molecular basis of the anti-cancer effects of histone deacetylase inhibitors","volume":"41","author":"Epping","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"issue":"July (4)","key":"10.1016\/j.leukres.2011.07.015_bib0045","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/med.20056","article-title":"Targeting histone deacetylase in cancer therapy","volume":"26","author":"Lin","year":"2006","journal-title":"Med Res Rev"},{"issue":"1 November (9)","key":"10.1016\/j.leukres.2011.07.015_bib0050","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1182\/blood.V98.9.2865","article-title":"Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report","volume":"98","author":"Piekarz","year":"2001","journal-title":"Blood"},{"issue":"May (3)","key":"10.1016\/j.leukres.2011.07.015_bib0055","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4161\/epi.3.3.6253","article-title":"A work in progress: the clinical development of histone deacetylase inhibitors","volume":"3","author":"Marsoni","year":"2008","journal-title":"Epigenetics"},{"key":"10.1016\/j.leukres.2011.07.015_bib0060","article-title":"The novel histone deacetylase inhibitor, AR-42, inhibits gp130\/Stat3 pathway and induces apoptosis and cell cycle arrest in multiple myeloma cells","author":"Zhang","year":"2010","journal-title":"Int J Cancer"},{"issue":"August (1)","key":"10.1016\/j.leukres.2011.07.015_bib0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0042-6822(83)90395-1","article-title":"Restricted expression of human T-cell leukemia\u2013lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes","volume":"129","author":"Salahuddin","year":"1983","journal-title":"Virology"},{"issue":"20","key":"10.1016\/j.leukres.2011.07.015_bib0070","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1126\/science.6980467","article-title":"Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line","volume":"217","author":"Yamamoto","year":"1982","journal-title":"Science"},{"issue":"15 December (24)","key":"10.1016\/j.leukres.2011.07.015_bib0075","first-page":"6977","article-title":"IL-2Ralpha-directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2\/IL-2Ralpha interaction","volume":"60","author":"Phillips","year":"2000","journal-title":"Cancer Res"},{"issue":"15 May (10)","key":"10.1016\/j.leukres.2011.07.015_bib0080","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1158\/0008-5472.CAN-08-0203","article-title":"OSU-HDAC42, a histone deacetylase inhibitor, blocks prostate tumor progression in the transgenic adenocarcinoma of the mouse prostate model","volume":"68","author":"Sargeant","year":"2008","journal-title":"Cancer Res"},{"issue":"1 September (17)","key":"10.1016\/j.leukres.2011.07.015_bib0085","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1158\/1078-0432.CCR-06-0429","article-title":"Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancer","volume":"12","author":"Kulp","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"May (3)","key":"10.1016\/j.leukres.2011.07.015_bib0090","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ctrv.2007.11.003","article-title":"Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors","volume":"34","author":"Duenas-Gonzalez","year":"2008","journal-title":"Cancer Treat Rev"},{"issue":"November (21)","key":"10.1016\/j.leukres.2011.07.015_bib0095","doi-asserted-by":"crossref","first-page":"9828","DOI":"10.1128\/JVI.74.21.9828-9835.2000","article-title":"Human T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytes","volume":"74","author":"Albrecht","year":"2000","journal-title":"J Virol"},{"issue":"5 September (39)","key":"10.1016\/j.leukres.2011.07.015_bib0100","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1038\/sj.onc.1208979","article-title":"Natural history of adult T-cell leukemia\/lymphoma and approaches to therapy","volume":"24","author":"Taylor","year":"2005","journal-title":"Oncogene"},{"issue":"1 October (19)","key":"10.1016\/j.leukres.2011.07.015_bib0105","first-page":"6453","article-title":"Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H","volume":"63","author":"Zhang","year":"2003","journal-title":"Cancer Res"},{"issue":"1 February (3)","key":"10.1016\/j.leukres.2011.07.015_bib0110","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1182\/blood-2004-05-1709","article-title":"Combination therapy for adult T-cell leukemia-xenografted mice: flavopiridol and anti-CD25 monoclonal antibody","volume":"105","author":"Zhang","year":"2005","journal-title":"Blood"},{"issue":"1 September (5)","key":"10.1016\/j.leukres.2011.07.015_bib0115","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1182\/blood-2002-01-0151","article-title":"Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells","volume":"100","author":"Mori","year":"2002","journal-title":"Blood"},{"issue":"1 August (3)","key":"10.1016\/j.leukres.2011.07.015_bib0120","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood-2003-11-3967","article-title":"Effects of the proteasome inhibitor PS-341 on tumor growth in HTLV-1 Tax transgenic mice and Tax tumor transplants","volume":"104","author":"Mitra-Kaushik","year":"2004","journal-title":"Blood"},{"issue":"May (5)","key":"10.1016\/j.leukres.2011.07.015_bib0125","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1349-7006.2010.01499.x","article-title":"A selective inhibitor MLN8237 suppresses the growth and survival of HTLV-1-infected T-cells in vitro","volume":"101","author":"Tomita","year":"2010","journal-title":"Cancer Sci"},{"issue":"May (9)","key":"10.1016\/j.leukres.2011.07.015_bib0130","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1128\/JVI.78.9.4582-4590.2004","article-title":"Apoptosis induced by the histone deacetylase inhibitor FR901228 in human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells","volume":"78","author":"Mori","year":"2004","journal-title":"J Virol"},{"issue":"5 February (6)","key":"10.1016\/j.leukres.2011.07.015_bib0135","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1182\/blood-2008-04-149658","article-title":"Effective treatment of a murine model of adult T-cell leukemia using depsipeptide and its combination with unmodified daclizumab directed toward CD25","volume":"113","author":"Chen","year":"2009","journal-title":"Blood"},{"issue":"September (17)","key":"10.1016\/j.leukres.2011.07.015_bib0140","doi-asserted-by":"crossref","first-page":"8537","DOI":"10.1128\/JVI.00690-08","article-title":"Small-molecule inhibitor which reactivates p53 in human T-cell leukemia virus type 1-transformed cells","volume":"82","author":"Jung","year":"2008","journal-title":"J Virol"},{"issue":"March (2)","key":"10.1016\/j.leukres.2011.07.015_bib0145","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF03259935","article-title":"Valproate-associated hepatotoxicity and its biochemical mechanisms","volume":"3","author":"Eadie","year":"1988","journal-title":"Med Toxicol Adverse Drug Exp"},{"issue":"28 September (39)","key":"10.1016\/j.leukres.2011.07.015_bib0150","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J Biol Chem"},{"issue":"15 July (14)","key":"10.1016\/j.leukres.2011.07.015_bib0155","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.1158\/0008-5472.CAN-05-0487","article-title":"Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo","volume":"66","author":"Xia","year":"2006","journal-title":"Cancer Res"},{"issue":"1 August (15)","key":"10.1016\/j.leukres.2011.07.015_bib0160","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1158\/1078-0432.CCR-05-2849","article-title":"Valproic Acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic medulloblastoma xenografts","volume":"12","author":"Shu","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"February (2)","key":"10.1016\/j.leukres.2011.07.015_bib0165","first-page":"248","article-title":"The effects of the histone deacetylase inhibitor valproic acid on cell cycle, growth suppression and apoptosis in multiple myeloma","volume":"91","author":"Kaiser","year":"2006","journal-title":"Haematologica"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611003584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611003584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T23:43:25Z","timestamp":1592783005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212611003584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0145212611003584"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2011.07.015","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}